No black box warning on record for Modafinil

As of the latest FDA labeling reviewed, Modafinil (MODAFINIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Modafinil medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious Rash, including Stevens-Johnson Syndrome: Discontinue modafinil at the first sign of rash, unless the rash is clearly not drug-related. ( 5.1 ) • Angioedema and Anaphylaxis Reactions: If suspected, discontinue modafinil. ( 5.2 ) • Multi-organ Hypersensitivity Reactions: If suspected, discontinue modafinil. ( 5.3 ) • Persistent Sleepiness: Assess patients freque

No black box warning on record for Modafinil

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious Rash, including Stevens-Johnson Syndrome: Discontinue modafinil at the first sign of rash, unless the rash is clearly not drug-related. ( 5.1 ) • Angioedema and Anaphylaxis Reactions: If suspected, discontinue modafinil. ( 5.2 ) • Multi-organ Hypersensitivity Reactions: If suspected, discontinue modafinil. ( 5.3 ) • Persistent Sleepiness: Assess patients freque

Modafinil Black Box Warning

No black box warning on record for Modafinil

Other warnings & precautions

Modafinil Black Box Warning

No black box warning on record for Modafinil

Other warnings & precautions